News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
829,692 Results
Type
Article (85499)
Company Profile (698)
Press Release (743495)
Section
Business (231905)
Career Advice (4110)
Deals (39649)
Drug Delivery (119)
Drug Development (90584)
Employer Resources (194)
FDA (17912)
Job Trends (17270)
News (394965)
Policy (39593)
Tag
Academia (2972)
Alliances (56433)
Alzheimer's disease (1338)
Approvals (17854)
Artificial intelligence (133)
Bankruptcy (394)
Best Places to Work (12449)
Biotechnology (483)
Breast cancer (148)
Cancer (1194)
Career advice (3515)
CAR-T (96)
Cell therapy (289)
Clinical research (71540)
Collaboration (413)
Compensation (206)
COVID-19 (2789)
C-suite (98)
Data (1159)
Diabetes (119)
Diagnostics (6606)
Earnings (94102)
Employer resources (166)
Events (126484)
Executive appointments (306)
FDA (18392)
Funding (355)
Gene therapy (202)
GLP-1 (642)
Government (5024)
Healthcare (20642)
Infectious disease (2861)
Inflammatory bowel disease (124)
Interviews (808)
IPO (17554)
Job creations (5179)
Job search strategy (2856)
Layoffs (485)
Legal (10017)
Lung cancer (172)
Manufacturing (190)
Medical device (14253)
Medtech (14258)
Mergers & acquisitions (22050)
Metabolic disorders (392)
Neuroscience (1630)
NextGen Class of 2024 (7646)
Non-profit (5049)
Northern California (1449)
Obesity (221)
Opinion (246)
Patents (102)
People (64112)
Pharmaceutical (141)
Phase I (22059)
Phase II (31088)
Phase III (23416)
Pipeline (446)
Podcasts (94)
Postmarket research (3538)
Preclinical (9970)
Radiopharmaceuticals (243)
Rare diseases (235)
Real estate (7368)
Regulatory (25878)
Research institute (2638)
Resumes & cover letters (649)
Southern California (1263)
Startups (4272)
United States (13274)
Vaccines (622)
Weight loss (178)
Date
Today (99)
Last 7 days (550)
Last 30 days (2286)
Last 365 days (34431)
2024 (33358)
2023 (42568)
2022 (53928)
2021 (58726)
2020 (57671)
2019 (51341)
2018 (39125)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1261)
Arizona (214)
Asia (49296)
Australia (8696)
California (3305)
Canada (1149)
China (270)
Colorado (104)
Connecticut (140)
Europe (112799)
Florida (380)
Illinois (345)
Indiana (195)
Kansas (103)
Maryland (602)
Massachusetts (2733)
Michigan (148)
Minnesota (252)
New Jersey (959)
New York (916)
North Carolina (805)
Northern California (1449)
Ohio (121)
Pennsylvania (757)
South America (1646)
Southern California (1263)
Texas (428)
Washington State (379)
829,692 Results for "takara bio".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Jumpcode Genomics and Takara Bio USA Announce Global Patent Partnership
Jumpcode Genomics and Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., announced the companies have settled their patent dispute and have partnered to bring together their combined foundational IP in the field of targeted depletion of undesired transcripts such as ribosomal RNAs from NGS libraries using CRISPR-based technology.
June 13, 2024
·
3 min read
Biotech Bay
Takara Bio Launches First Commercial Dissolvable Microfluidic Lentiviral Transduction Enhancer
Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., announced the launch of the Lenti-X™ Transduction Sponge, a first-to-market dissolvable microfluidic transduction enhancer that innovates in vitro lentivirus-mediated gene delivery techniques.
May 6, 2024
·
3 min read
Press Releases
Takara Bio Launches High-Throughput, Cost-Effective qPCR System to Advance Clinical Research
November 20, 2024
·
3 min read
Biotech Bay
Takara Bio transforms single-cell landscape with new large-scale NGS profiling system for oncology biomarker discovery
Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., announced the launch of the Shasta™ Single-Cell System, an automated, high-throughput NGS solution with well-validated chemistries and intuitive bioinformatics tools that enables novel biomarker discovery for oncology research.
April 2, 2024
·
4 min read
Biotech Bay
Takara Bio’s First-to-Market Large-Scale Single-Cell NGS Profiling Technologies Poised to Revolutionize Biomarker Discovery
Takara Bio USA, Inc. today announced plans to launch two critical solutions for oncology research. These automated single-cell total RNA-seq and DNA-seq library preparation kits will provide high sample and cell throughput, less hands-on time, and the ability to capture more information than other available technologies.
February 5, 2024
·
3 min read
Biotech Bay
Takara Bio USA Wins EU Opposition Hearing, Revoking Jumpcode Genomics’ NGS Library Enrichment Patent
Takara Bio USA, Inc. announced that it has once again prevailed in its second patent dispute with Jumpcode Genomics, Inc.
December 11, 2023
·
2 min read
Business
Takara Bio USA, Inc. and BioExcel Diagnostics Partner for Development of Wide-Coverage Infectious Disease Detection Panels
Takara Bio USA, Inc., a pioneering life science reagent and instrument company and wholly owned subsidiary of Takara Bio Inc., is partnering with BioExcel Diagnostics to develop and validate a new high-throughput and comprehensive method for detecting syndromic-based infectious diseases.
October 17, 2022
·
4 min read
Layoffs
Bluebird Bio to Lay Off 25% of Workforce
About a month after reporting it’s had a tough time starting enough patients on its treatments, bluebird bio announced it will lay off about 25% of its employees, over half of whom work in R&D.
September 24, 2024
·
1 min read
·
Angela Gabriel
Press Releases
Mercury Bio Appoints Biotech Innovator Alex Koglin, Ph.D. to Board of Directors
With the addition of NTx’s co-founder and former President to the board Mercury Bio significantly enhances its strategic reach in the biotech sector
October 1, 2024
·
2 min read
Layoffs
IN8bio to Lay Off About 49% of Employees
Facing financial challenges, IN8bio is looking to preserve cash resources through a pipeline prioritization and layoffs at its New York City and Birmingham, Alabama, sites.
September 5, 2024
·
1 min read
·
Angela Gabriel
1 of 82,970
Next